𝔖 Bobbio Scriptorium

✦ LIBER ✦

TCT-35 Evaluation of the Absorb Everolimus Eluting Bioresorbable Vascular Scaffold (Absorb BVS) in the Treatment of Patients with de Novo Native Coronary Artery Lesions: 3 Year Clinical Results of the ABSORB Cohort B1 Trial

✍ Scribed by Peter Smits

Book ID: 119272109
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 57 KB
Volume: 60
Category: Article
ISSN: 1558-3597
DOI: 10.1016/j.jacc.2012.08.043

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

EVALUATION OF THE ABSORB EVEROLIMUS ELUT

EVALUATION OF THE ABSORB EVEROLIMUS ELUTING BIORESORBABLE VASCULAR SCAFFOLD (ABSORB BVS) IN THE TREATMENT OF PATIENTS WITH DE NOVO NATIVE CORONARY ARTERY LESIONS: 2 YEAR CLINICAL RESULTS OF ABSORB COHORT B TRIAL

✍ Dariusz Dudek 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 104 KB

THE ABSORB TRIAL: EVALUATION OF THE ABSO

THE ABSORB TRIAL: EVALUATION OF THE ABSORB EVEROLIMUS ELUTING BIORESORBABLE VASCULAR SCAFFOLD IN THE TREATMENT OF PATIENTS WITH DE NOVO NATIVE CORONARY ARTERY LESIONS: 4 YEAR CLINICAL RESULTS OF COHORT B

✍ Christiansen, Evald Hoej 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 181 KB

ABSORB EVALUATION OF THE BIORESORBABLE E

ABSORB EVALUATION OF THE BIORESORBABLE EVEROLIMUS-ELUTING VASCULAR SCAFFOLD (BVS) IN THE TREATMENT OF PATIENTS WITH DE NOVO NATIVE CORONARY ARTERY LESIONS: 1 YEAR CLINICAL RESULTS OF COHORT B

✍ Chevalier, Bernard 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 120 KB

TCT-245: ABSORB Cohort B Trial: Two Year

TCT-245: ABSORB Cohort B Trial: Two Year Clinical and Angiographic Results of the ABSORB Bioresorbable Everolimus Eluting Vascular Scaffold

📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 172 KB

TCT-37: ABSORB Cohort B Trial: 9 Months

TCT-37: ABSORB Cohort B Trial: 9 Months Clinical Results of the Evaluation of the Bioresorbable Everolimus-Eluting Vascular Scaffold (BVS) in the Treatment of Patients with de Novo Native Coronary Artery Lesions

📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 146 KB

TCT-32 First Report of the Four Year Cli

TCT-32 First Report of the Four Year Clinical Results of The ABSORB Trial Evaluating the Absorb Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Patients with de Novo Native Coronary Artery Lesions

✍ Chevalier, Bernard 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 54 KB